Clinical Trial Update: Viral Inhibition in Children for Treatment of RSV [Phase 2]

View source ↗

Summary

Phase 2 trial update on viral inhibition for respiratory syncytial virus infections in children; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Snippet

Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS | Phase 2 | Status: COMPLETED